4//SEC Filing
Sunshine Biopharma, Inc 4
Accession 0001128732-15-000001
$SBFMCIK 0001402328operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 11:48 AM ET
Size
7.0 KB
Accession
0001128732-15-000001
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock
2015-01-09$0.02/sh+150,000$3,000→ 384,373 total - Other
Common Stock
2015-01-09$0.02/sh−1,200,000$24,000→ 30,317,694 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)
Footnotes (2)
- [F1]Advanomics Corporation, an entity controlled by Reporting Person, acquired intellectual properties in exchange for the transfer of 1,200,000 shares of the Issuer's Common Stock to 5 entities or persons, 150,000 shares of which having been transferred to the Reporting Person in the transaction. See Footnote 2.
- [F2]Reporting Person acquired 150,000 shares of the Issuer's Common Stock from Advanomics Corporation, an entity controlled by the Reporting Person, in exchange for interests in intellectual properties transferred to Advanomics Corporation. See Footnote 1.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeoperating
IncorporatedCO
Related Parties
1- filerCIK 0001402328
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 11:48 AM ET
- Size
- 7.0 KB